Placebo + SOTAGLIFLOZIN for albuminuria

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 27 Nov 2023: Trial registered, NCT06147232

The trials

NCT06147232: Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia

State
Not started
Phase
Phase 2
People
69 planned
Started
Feb 2025
Primary completion
May 2027
Arms
order: placebo/sotagliflozin, order: sotagliflozin/placebo
Results
None posted
  1. 27 Nov 2023: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.